SIC
NUVB icon

Salem Investment Counselors’s Nuvation Bio NUVB Stock Holding History

Salem Investment Counselors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.25K Hold
1,100
– – ﹤0.01% 979
2026
Q1 		$4.72K Buy
+1,100
New +$6.13K ﹤0.01% 976

Other funds holding NUVB

ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $3.25B AUM 41% 1-Year Est. Return

Salem Investment Counselors's NUVB Position: Q2 2026 in Review

Salem Investment Counselors held its Nuvation Bio (NUVB) position steady in Q2 2026 at 1,100 shares worth $6.25K. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Salem Investment Counselors first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Salem Investment Counselors held 1,100 shares of Nuvation Bio worth $6.25K as of Q2 2026.
  • Salem Investment Counselors left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #979 holding.
  • Salem Investment Counselors first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.